Erasca is based out of San Diego. Erasca, Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The firm last filed a Form D notice of exempt offering of securities on 2020-04-30. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
ERASCA, INC.10835 ROAD TO THE CURE, SUITE 140
SAN DIEGO CA 92121
Business Phone: (858) 465-6511
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS